Strumento inattivo

Azioni Paulson Capital Corp. Nasdaq

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

VBI Vaccines : Applies its eVLP Platform in the Development of a Novel Vaccine Candidate to Prevent Zika Virus	25/07/16
VBI Vaccines : Appoints Dr. Francisco Diaz-Mitoma as Chief Medical Officer	25/07/16
VBI Vaccines : Applies its eVLP Platform in the Development of a Novel Vaccine Candidate to Prevent Zika Virus	19/07/16
VBI Vaccines : Researchers Explore the Mechanisms by Which CMV Infection May Impact Fetal Brain Development	14/07/16
VBI Vaccines : Begins Enrolling Patients in a Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate	13/07/16

Settore

	Variaz. 1 gen.	Capi.
CSL LIMITED	+0,82%	91,38 Mrd
SAMSUNG BIOLOGICS CO.,LTD.	-3,16%	38,68 Mrd
BIOGEN INC.	-9,63%	33,58 Mrd
UCB	+72,31%	27,84 Mrd
BIOMARIN PHARMACEUTICAL INC.	-12,63%	16,05 Mrd
INCYTE CORPORATION	-0,16%	13,48 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,38%	11,73 Mrd
ALTEOGEN INC.	+172,59%	10,74 Mrd
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-49,44%	10,39 Mrd